Share-based Payment Arrangement, Expense in USD of 10x Genomics, Inc. from 2017 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
10x Genomics, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from 2017 to Q3 2025.
  • 10x Genomics, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2025 was $25.3M, a 25.5% decline year-over-year.
  • 10x Genomics, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2025 was $116M, a 21.5% decline year-over-year.
  • 10x Genomics, Inc. annual Share-based Payment Arrangement, Expense for 2024 was $141M, a 15.7% decline from 2023.
  • 10x Genomics, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $167M, a 22% increase from 2022.
  • 10x Genomics, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $137M, a 42.6% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

10x Genomics, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $116M $25.3M -$8.65M -25.5% 01 Jul 2025 30 Sep 2025 10-Q 07 Nov 2025
Q2 2025 $124M $27.2M -$11.2M -29.2% 01 Apr 2025 30 Jun 2025 10-Q 08 Aug 2025
Q1 2025 $136M $31.1M -$5.05M -14% 01 Jan 2025 31 Mar 2025 10-Q 09 May 2025
Q4 2024 $141M $32.2M -$6.7M -17.2% 01 Oct 2024 31 Dec 2024 10-K 13 Feb 2025
Q3 2024 $147M $33.9M -$6.33M -15.7% 01 Jul 2024 30 Sep 2024 10-Q 07 Nov 2025
Q2 2024 $154M $38.5M -$7.2M -15.8% 01 Apr 2024 30 Jun 2024 10-Q 08 Aug 2025
Q1 2024 $161M $36.1M -$5.97M -14.2% 01 Jan 2024 31 Mar 2024 10-Q 09 May 2025
Q4 2023 $167M $38.9M -$2.06M -5.02% 01 Oct 2023 31 Dec 2023 10-K 13 Feb 2025
Q3 2023 $169M $40.2M +$6.72M +20.1% 01 Jul 2023 30 Sep 2023 10-Q 29 Oct 2024
Q2 2023 $162M $45.7M +$9.38M +25.8% 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024
Q1 2023 $153M $42.1M +$16.1M +61.6% 01 Jan 2023 31 Mar 2023 10-Q 30 Apr 2024
Q4 2022 $137M $41M +$14.1M +52.3% 01 Oct 2022 31 Dec 2022 10-K 13 Feb 2025
Q3 2022 $123M $33.5M +$7.56M +29.1% 01 Jul 2022 30 Sep 2022 10-Q 03 Nov 2023
Q2 2022 $115M $36.3M +$9.38M +34.8% 01 Apr 2022 30 Jun 2022 10-Q 04 Aug 2023
Q1 2022 $106M $26M +$9.87M +61% 01 Jan 2022 31 Mar 2022 10-Q 04 May 2023
Q4 2021 $96M $26.9M +$12.6M +88.5% 01 Oct 2021 31 Dec 2021 10-K 15 Feb 2024
Q3 2021 $83.3M $26M +$12.2M +88.3% 01 Jul 2021 30 Sep 2021 10-Q 03 Nov 2022
Q2 2021 $71.2M $26.9M +$13.1M +94.4% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022
Q1 2021 $58.1M $16.2M +$9.46M +141% 01 Jan 2021 31 Mar 2021 10-Q 05 May 2022
Q4 2020 $48.6M $14.3M +$9.19M +181% 01 Oct 2020 31 Dec 2020 10-K 16 Feb 2023
Q3 2020 $39.4M $13.8M +$9.91M +256% 01 Jul 2020 30 Sep 2020 10-Q 05 Nov 2021
Q2 2020 $29.5M $13.9M +$10.8M +358% 01 Apr 2020 30 Jun 2020 10-Q 06 Aug 2021
Q1 2020 $18.7M $6.72M +$5.36M +394% 01 Jan 2020 31 Mar 2020 10-Q 07 May 2021
Q4 2019 $13.3M $5.08M 01 Oct 2019 31 Dec 2019 10-K 18 Feb 2022
Q3 2019 $3.87M +$3.29M +558% 01 Jul 2019 30 Sep 2019 10-Q 12 Nov 2020
Q2 2019 $3.03M 01 Apr 2019 30 Jun 2019 10-Q 12 Aug 2020
Q1 2019 $1.36M 01 Jan 2019 31 Mar 2019 10-Q 12 May 2020
Q3 2018 $589K 01 Jul 2018 30 Sep 2018 10-Q 12 Nov 2019

10x Genomics, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $141M -$26.2M -15.7% 01 Jan 2024 31 Dec 2024 10-K 13 Feb 2025
2023 $167M +$30.1M +22% 01 Jan 2023 31 Dec 2023 10-K 13 Feb 2025
2022 $137M +$40.9M +42.6% 01 Jan 2022 31 Dec 2022 10-K 13 Feb 2025
2021 $96M +$47.3M +97.3% 01 Jan 2021 31 Dec 2021 10-K 15 Feb 2024
2020 $48.6M +$35.3M +265% 01 Jan 2020 31 Dec 2020 10-K 16 Feb 2023
2019 $13.3M +$10.7M +402% 01 Jan 2019 31 Dec 2019 10-K 18 Feb 2022
2018 $2.66M +$997K +60% 01 Jan 2018 31 Dec 2018 10-K 26 Feb 2021
2017 $1.66M 01 Jan 2017 31 Dec 2017 10-K 27 Feb 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.